Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $204B
1-Year Return 26.64%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Quarter Return
+9.85%
1 Year Return
+26.64%
3 Year Return
+125.28%
5 Year Return
+196.8%
10 Year Return
+578.78%
AUM
$161B
AUM Growth
+$9.13B
Cap. Flow
-$2.43B
Cap. Flow %
-1.51%
Top 10 Hldgs %
24.44%
Holding
2,758
New
73
Increased
782
Reduced
1,689
Closed
166

Sector Composition

1 Technology 32.66%
2 Healthcare 19.35%
3 Industrials 10.04%
4 Financials 10%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ACET icon
2626
Adicet Bio
ACET
$59.6M
-10,632
Closed -$61.2K
ADV icon
2627
Advantage Solutions
ADV
$580M
-30,763
Closed -$48.9K
AEVA
2628
Aeva Technologies
AEVA
$755M
-9,260
Closed -$55.1K
ALT icon
2629
Altimmune
ALT
$324M
-23,986
Closed -$101K
AMRX icon
2630
Amneal Pharmaceuticals
AMRX
$3B
-44,720
Closed -$62.6K
ARCC icon
2631
Ares Capital
ARCC
$15.8B
-173,845
Closed -$3.18M
ARTNA icon
2632
Artesian Resources
ARTNA
$342M
-4,223
Closed -$233K
ATNI icon
2633
ATN International
ATNI
$253M
-4,943
Closed -$202K
ATRA icon
2634
Atara Biotherapeutics
ATRA
$89.9M
-1,313
Closed -$95K
AVIR icon
2635
Atea Pharmaceuticals
AVIR
$264M
-35,909
Closed -$120K
BAER icon
2636
Bridger Aerospace
BAER
$111M
-14,772
Closed -$67.2K
BIRD icon
2637
Allbirds
BIRD
$51.9M
-2,079
Closed -$49.7K
BNGO icon
2638
Bionano Genomics
BNGO
$17.8M
-211
Closed -$140K
CCCC icon
2639
C4 Therapeutics
CCCC
$202M
-11,081
Closed -$34.7K
CCEP icon
2640
Coca-Cola Europacific Partners
CCEP
$40.2B
-106,236
Closed -$6.29M
CDXS icon
2641
Codexis
CDXS
$223M
-25,507
Closed -$105K
CIO
2642
City Office REIT
CIO
$281M
-19,417
Closed -$134K
CMTL icon
2643
Comtech Telecommunications
CMTL
$63.2M
-11,899
Closed -$148K
CRBU icon
2644
Caribou Biosciences
CRBU
$174M
-25,333
Closed -$135K
CRCT icon
2645
Cricut
CRCT
$1.25B
-12,548
Closed -$128K
CSTL icon
2646
Castle Biosciences
CSTL
$681M
-9,296
Closed -$211K
DINO icon
2647
HF Sinclair
DINO
$9.54B
-35,963
Closed -$1.74M
DOUG icon
2648
Douglas Elliman
DOUG
$246M
-43,397
Closed -$129K
ECX icon
2649
ECARX Holdings
ECX
$571M
-24,997
Closed -$146K
EE icon
2650
Excelerate Energy
EE
$750M
-9,220
Closed -$204K